What You Need to Know to Avoid Costly Delays in Your API Scale-Up

What You Need to Know to Avoid Costly Delays in Your API Scale-UpTraditionally, the development of a small-scale synthesis for an active pharmaceutical ingredient (API) and its scale-up to meet the materials demand for clinical trial phases is a sequential activity that passes through multiple sets of hands. Even if the synthesis used at a small scale is the same one used at a large scale, the developer must be prepared to encounter and react to any changes to the API’s quality attributes, such as by-product profile and physical form.

Learn why a company must be aware of any potential conditions that could occur at a small-scale that could create major issues during commercial scale-up.

Author: Peter Poechlauer, Innovation Manager, Patheon

Resource Library

Related Sites

Bend, OR

Bend, OR

Bourgoin, FR

Bourgoin, FR

Cork, Ireland

Cork, Ireland

Florence, SC (East)

Florence, SC (East)

Florence, SC (West)

Florence, SC (West)

Greenville, SC

Greenville, SC

Linz, AT

Linz, AT

Regensburg, DE

Regensburg, DE

Additional Resources